Avoset Health said this week that it plans to develop a connected infusion pump with an unnamed pharmaceutical company. The product is set to debut in early 2021.

The company touted that its technology allows physicians and pharmacists to track when patients receive infusions, how much drug was infused and which patients need additional intervention.

Users can connect to the pre-programmed infusion pump and begin treatment with the click of a button, Avoset added.

“Our belief is that providing data from the homecare infusion setting will enable providers to make necessary adjustments to the current standard of care for improved patient outcomes,” Avoset CEO Shaul Eitan said in prepared remarks. “Combining our partner’s extensive knowledge, market access and true forward-looking vision with Avoset’s product innovation can advance dedicated infusion towards a value and outcomes-based approach through quantifiable data access.”

“Avoset’s existing technology and Eitan Group’s manufacturing, regulatory and R&D capabilities made Avoset the clear choice to develop the next generation of connected dedicated pump solutions,” a spokesperson from the pharma partner added. “We have complementary expertise; Avoset’s innovation combined with our mature medical and pharmaceutical devices will help patients around the world get more effective treatment.”